Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Cancer Research
|
December 30, 2021
Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy
Songfa Zhang, Chuan Yan, David G Millar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 4, 2018
Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer
Clemens Grassberger, Theodore S Hong, Tai Hato, et al.
Molecular Cancer Therapeutics
|
March 3, 2021
Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR
Shenlan Mao, Raghothama Chaerkady, Wen Yu, et al.
European Journal of Immunology
|
May 15, 2014
Resolving Salmonella infection reveals dynamic and persisting changes in murine bone marrow progenitor cell phenotype and function
Ewan A Ross, Adriana Flores-Langarica, Saeeda Bobat, et al.
The Journal of Experimental Medicine
|
August 20, 2021
Single-cell imaging of T cell immunotherapy responses in vivo
Chuan Yan, Qiqi Yang, Songfa Zhang, et al.
Journal for Immunotherapy of Cancer
|
April 17, 2025
LILRB2 blockade facilitates macrophage repolarization and enhances T cell-mediated antitumor immunity
Des C Jones, Lorraine Irving, Rebecca Dudley, et al.
Journal for Immunotherapy of Cancer
|
May 10, 2020
MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma
Victor H Engelhard, Rebecca C Obeng, Kara L Cummings, et al.
Journal for Immunotherapy of Cancer
|
November 25, 2020
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma
Kohei Shigeta, Aya Matsui, Hiroto Kikuchi, et al.
Science Translational Medicine
|
September 20, 2013
MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia
Mark Cobbold, Hugo De La Peña, Andrew Norris, et al.
Journal for Immunotherapy of Cancer
|
August 4, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release
Miguel Gaspar, Marina Natoli, Laure Castan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Cancer Research
|
December 30, 2021
Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy
Songfa Zhang, Chuan Yan, David G Millar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 4, 2018
Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer
Clemens Grassberger, Theodore S Hong, Tai Hato, et al.
Molecular Cancer Therapeutics
|
March 3, 2021
Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR
Shenlan Mao, Raghothama Chaerkady, Wen Yu, et al.
European Journal of Immunology
|
May 15, 2014
Resolving Salmonella infection reveals dynamic and persisting changes in murine bone marrow progenitor cell phenotype and function
Ewan A Ross, Adriana Flores-Langarica, Saeeda Bobat, et al.
The Journal of Experimental Medicine
|
August 20, 2021
Single-cell imaging of T cell immunotherapy responses in vivo
Chuan Yan, Qiqi Yang, Songfa Zhang, et al.
Journal for Immunotherapy of Cancer
|
April 17, 2025
LILRB2 blockade facilitates macrophage repolarization and enhances T cell-mediated antitumor immunity
Des C Jones, Lorraine Irving, Rebecca Dudley, et al.
Journal for Immunotherapy of Cancer
|
May 10, 2020
MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma
Victor H Engelhard, Rebecca C Obeng, Kara L Cummings, et al.
Journal for Immunotherapy of Cancer
|
November 25, 2020
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma
Kohei Shigeta, Aya Matsui, Hiroto Kikuchi, et al.
Science Translational Medicine
|
September 20, 2013
MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia
Mark Cobbold, Hugo De La Peña, Andrew Norris, et al.
Journal for Immunotherapy of Cancer
|
August 4, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release
Miguel Gaspar, Marina Natoli, Laure Castan, et al.
Page
of 6